<?xml version="1.0" encoding="UTF-8"?>
<p>The most frequent adverse event reported according to the organ classes was of respiratory, thoracic and mediastinal disorders both in vaccine group (36.84%) and placebo group (23.26%), and the second most frequent adverse event was of infections and infestations both in vaccine group (15.79%) and placebo group (18.6%) (
 <xref rid="F0001">Figure 1</xref>). The most frequent systemic reaction was post-nasal drippings in both groups after the first immunization (
 <xref rid="F0002">Figure 2</xref>).
</p>
